BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

GW Pharmaceuticals Ltd. 

Porton Down Science Park

Salisbury  Wiltshire  SP4 0JQ  United Kingdom
Phone: 44-1980-619000 Fax: +44-1980-619111


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical






 Company News
GW Pharma (GWPH) Relocates CEO and Taps Ex-Allergan (AGN) Exec to Lead U.S. Biz in SoCal 5/19/2015 7:35:43 AM
GW Pharma (GWPH) Announces Full Exercise Of Underwriters' Option To Purchase Additional American Depositary Shares 5/17/2015 4:50:20 PM
GW Pharma (GWPH) Reports Second Quarter 2015 Financial Results And Operational Progress 5/11/2015 10:44:45 AM
GW Pharma (GWPH) To Present At Bank of America (BAC) Merrill Lynch 2015 Healthcare Conference 5/11/2015 10:40:14 AM
GW Pharma (GWPH) Initiates Phase 3 Pivotal Study Of Epidiolex (CBD) In Lennox-Gastaut Syndrome 5/11/2015 7:39:27 AM
GW Pharma (GWPH) To Report Q2 2015 Financial Results And Host Conference Call On 11 May, 2015 5/6/2015 10:52:59 AM
GW Pharma (GWPH) Initiates Phase 2 Clinical Study Of Cannabidivarin (CBDV) In Epilepsy 5/6/2015 7:18:31 AM
GW Pharma (GWPH) Raises $179.2 Million NASDAQ Cash 4/29/2015 6:45:59 AM
GW Pharmaceuticals (GWPH) Announces Proposed Public Offering Of ADSs 4/28/2015 7:43:26 AM
GW Pharmaceuticals (GWPH) Announces Us Patent Allowance For Use Of Cannabidivarin (CBDV) In Treating Epilepsy 4/27/2015 7:38:15 AM
12345678910...